Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis

Seminars in Respiratory and Critical Care Medicine

Volumn 36, Issue 2, 2015, Pages 251-266

  Main, Eleanor ^a   Grillo, Lizzie ^a,b   Rand, Sarah ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

breathing exercises; bronchiectasis; cystic fibrosis; inhalation therapy; physiotherapy (techniques); positive pressure respiration; rehabilitation; respiratory

Indexed keywords

DORNASE ALFA; EXPECTORANT AGENT; MANNITOL; MUCOLYTIC AGENT; SODIUM CHLORIDE; DEOXYRIBONUCLEASE I; RECOMBINANT PROTEIN;

ACTIVE CYCLE OF BREATHING TECHNIQUE; AIRWAY CLEARANCE TECHNIQUE; ARTICLE; ASSISTED AUTOGENIC DRAINAGE; AUTOGENIC DRAINAGE; BREATHING EXERCISE; BREATHING RATE; BRONCHIECTASIS; CLINICAL FEATURE; CYSTIC FIBROSIS; EXERCISE; HIGH FREQUENCY CHEST WALL OSCILLATION; HUMAN; HUMIDIFIER; MANUAL TECHNIQUE; MEDICATION COMPLIANCE; MODIFIED POSTURAL DRAINAGE; NON CONTINUOUS VENTILATOR; NON CYSTIC FIBROSIS BRONCHIECTASIS; NONINVASIVE VENTILATION; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PEAK INSPIRATORY FLOW; PHYSICAL CAPACITY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; POSTURAL DRAINAGE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY CARE; SPIROMETRY; SPUTUM; TIDAL VOLUME; COUGHING; LUNG; MOTOR ACTIVITY; MUCOCILIARY CLEARANCE; PHYSIOLOGY;

BRONCHIECTASIS; COUGH; CYSTIC FIBROSIS; DEOXYRIBONUCLEASE I; HUMANS; LUNG; MANNITOL; MOTOR ACTIVITY; MUCOCILIARY CLEARANCE; RECOMBINANT PROTEINS; RESPIRATORY THERAPY; SALINE SOLUTION, HYPERTONIC;

EID: 84926219241     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0035-1546820     Document Type: Article

References (171)

1. Sontag M. K., Quittner A. L., Modi A. C., et al. Investigators and Coordinators of the Airway Secretion Clearance Trial. Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatr Pulmonol: 2010; 45 3 291 300
2. McIlwaine M., Wong L. T., Chilvers M., Davidson G. F. Long-term comparative trial of two different physiotherapy techniques; postural drainage with percussion and autogenic drainage, in the treatment of cystic fibrosis. Pediatr Pulmonol: 2010; 45 11 1064 1069
3. McIlwaine M. P., Alarie N., Davidson G. F., et al. Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax: 2013; 68 8 746 751
4. Pryor J. A., Tannenbaum E., Scott S. F., et al. Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis. J Cyst Fibros: 2010; 9 3 187 192
5. Main E. What is the best airway clearance technique in cystic fibrosis? Paediatr Respir Rev: 2013; 14 01 10 12
6. Brewin C. R., Bradley C. Patient preferences and randomised clinical trials. BMJ: 1989; 299 6694 313 315
7. Warnock L., Gates A., van der Schans C. P. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst Rev: 2013; 9 CD001401
8. Elkins M. R., Jones A., van der Schans C. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev: 2006; 2 CD003147
9. Morrison L., Agnew J. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev: 2014; 7 CD006842
10. Main E., Prasad A., Schans C. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev: 2005; 1 CD002011
11. McKoy N. A., Saldanha I. J., Odelola O. A., Robinson K. A. Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst Rev: 2012; 12 CD007862
12. Murray M. P., Hill A. T. Non-cystic fibrosis bronchiectasis. Clin Med: 2009; 9 2 164 169
13. Pryor J. A. Physiotherapy for airway clearance in adults. Eur Respir J: 1999; 14 6 1418 1424
14. O'Donohoe R., Fullen B. M. Adherence of subjects with cystic fibrosis to their home program: a systematic review. Respir Care: 2014; 59 11 1731 1746
15. Myers L. B. An exploratory study investigating factors associated with adherence to chest physiotherapy and exercise in adults with cystic fibrosis. J Cyst Fibros: 2009; 8 6 425 427
16. Browne W. J., Wood C. J., Desai M., Weller P. H. Urinary incontinence in 9-16 year olds with cystic fibrosis compared to other respiratory conditions and a normal group. J Cyst Fibros: 2009; 8 1 50 57
17. Nankivell G., Caldwell P., Follett J. Urinary incontinence in adolescent females with cystic fibrosis. Paediatr Respir Rev: 2010; 11 2 95 99
18. Rees J., Tedd H., Soyza A. D. Managing urinary incontinence in adults with bronchiectasis. Br J Nurs: 2013; 22 9 S15 S16, S18
19. Laurin L. P., Jobin V., Bellemare F. Sternum length and rib cage dimensions compared with bodily proportions in adults with cystic fibrosis. Can Respir J: 2012; 19 3 196 200
20. Goldbeck L., Fidika A., Herle M., Quittner A. L. Psychological interventions for individuals with cystic fibrosis and their families. Cochrane Database Syst Rev: 2014; 6 CD003148
21. Jamieson N., Fitzgerald D., Singh-Grewal D., Hanson C. S., Craig J. C., Tong A. Children's experiences of cystic fibrosis: a systematic review of qualitative studies. Pediatrics: 2014; 133 6 e1683 e1697
22. Cramm J. M., Strating M. M., Roebroeck M. E., Nieboer A. P. The Importance of General Self-Efficacy for the Quality of Life of Adolescents with Chronic Conditions. Soc Indic Res: 2013; 113 1 551 561
23. McDonald C. M., Haberman D., Brown N. Self-efficacy: empowering parents of children with cystic fibrosis. J Cyst Fibros: 2013; 12 5 538 543
24. Simmons L. A., Wolever R. Q., Bechard E. M., Snyderman R. Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease. Genome Med: 2014; 6 2 16
25. Lavery K. A., O'Neill B., Parker M., Elborn J. S., Bradley J. M. Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial. Arch Phys Med Rehabil: 2011; 92 8 1194 1201
26. Bott J., Blumenthal S., Buxton M., et al. British Thoracic Society Physiotherapy Guideline Development Group. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax: 2009; 64 01 i1 i51
27. Pasteur M. C., Bilton D., Hill A. T.; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax: 2010; 65 01 i1 i58
28. Standards of Care and Good Clinical Practice for the Physiotherapy Management of Cystic Fibrosis. 2nd ed. London. Cystic Fibrosis Trust 2011
29. Lannefors L., Button B. M., McIlwaine M. Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments. J R Soc Med: 2004; 97 44 8 25
30. Barbato A., Frischer T., Kuehni C. E., et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J: 2009; 34 6 1264 1276
31. Schechter M. S. Airway clearance applications in infants and children. Respir Care: 2007; 52 10 1382 1390, discussion 1390-1391
32. Southern K. W., Munck A., Pollitt R., et al. ECFS CF Neonatal Screening Working Group. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros: 2007; 6 1 57 65
33. Massie J., Clements B.; Australian Paediatric Respiratory Group. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience-twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol: 2005; 39 5 440 446
34. Prasad S. A., Main E., Dodd M. E.; Association of Chartered Physiotherapists. Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis. Pediatr Pulmonol: 2008; 43 3 236 244
35. Prasad S. A., Main E. Routine airway clearance in asymptomatic infants and babies with cystic fibrosis in the UK: obligatory or obsolete? Phys Ther Rev: 2006; 11 1 11 20
36. Rosenfeld M., Gibson R. L., McNamara S., et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol: 2001; 32 5 356 366
37. Khan T. Z., Wagener J. S., Bost T., Martinez J., Accurso F. J., Riches D. W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med: 1995; 151 4 1075 1082
38. Armstrong D. S., Grimwood K., Carzino R., Carlin J. B., Olinsky A., Phelan P. D. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ: 1995; 310 6994 1571 1572
39. Nguyen T. T., Thia L. P., Hoo A. F., et al. London Cystic Fibrosis Collaboration (LCFC). Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax: 2014; 69 10 910 917
40. Button B. M., Heine R. G., Catto-Smith A. G., Phelan P. D., Olinsky A. Chest physiotherapy, gastro-oesophageal reflux, and arousal in infants with cystic fibrosis. Arch Dis Child: 2004; 89 5 435 439
41. Ewart W. The treatment of bronchiectasis and of chronic bronchial affections by posture and by respiratory exercises. Lancet: 1901; 2 4603 70 72
42. Lee A. L., Button B. M., Denehy L., et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology: 2014; 19 2 211 217
43. Button B. M., Heine R. G., Catto-Smith A. G., Phelan P. D., Olinsky A. Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis. Arch Dis Child: 1997; 76 2 148 150
44. Cecins N. M., Jenkins S. C., Pengelley J., Ryan G. The active cycle of breathing techniques-to tip or not to tip? Respir Med: 1999; 93 9 660 665
45. Eaton T., Young P., Zeng I., Kolbe J. A randomized evaluation of the acute efficacy, acceptability and tolerability of flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis. Chron Respir Dis: 2007; 4 1 23 30
46. Tsang S., Jones A. Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiother J: 2003; 21 1 29 36
47. Currie D. C., Munro C., Gaskell D., Cole P. J. Practice, problems and compliance with postural drainage: a survey of chronic sputum producers. Br J Dis Chest: 1986; 80 3 249 253
48. Mazzocco M. C., Owens G. R., Kirilloff L. H., Rogers R. M. Chest percussion and postural drainage in patients with bronchiectasis. Chest: 1985; 88 3 360 363
49. Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respir Med: 1991; 85 1 45 51
50. Rand S., Hill L., Prasad S. A. Physiotherapy in cystic fibrosis: optimising techniques to improve outcomes. Paediatr Respir Rev: 2013; 14 4 263 269
51. McCarren B., Alison J. A. Physiological effects of vibration in subjects with cystic fibrosis. Eur Respir J: 2006; 27 6 1204 1209
52. Pryor J. A., Webber B. A., Hodson M. E., Batten J. C. Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. BMJ: 1979; 2 6187 417 418
53. Webber B. A., Pryor J. A. Respiratory physiotherapy for cystic fibrosis. J Pediatr: 1989; 115 1 167 168
54. Volpe M. S., Adams A. B., Amato M. B., Marini J. J. Ventilation patterns influence airway secretion movement. Respir Care: 2008; 53 10 1287 1294
55. Flude L. J., Agent P., Bilton D. Chest physiotherapy techniques in bronchiectasis. Clin Chest Med: 2012; 33 2 351 361
56. Fink J. B. Forced expiratory technique, directed cough, and autogenic drainage. Respir Care: 2007; 52 9 1210 1221, discussion 1221-1223
57. Hasani A., Pavia D., Agnew J. E., Clarke S. W. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity. Thorax: 1994; 49 6 557 561
58. Phillips G. E., Pike S. E., Jaffé A., Bush A. Comparison of active cycle of breathing and high-frequency oscillation jacket in children with cystic fibrosis. Pediatr Pulmonol: 2004; 37 1 71 75
59. O'Neill B., Bradley J. M., McArdle N., MacMahon J. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int J Clin Pract: 2002; 56 1 34 35
60. Thompson C. S., Harrison S., Ashley J., Day K., Smith D. L. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax: 2002; 57 5 446 448
61. Lee A. L., Burge A., Holland A. E. Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev: 2013; 5 CD008351
62. Sutton P. P., Gemmell H. G., Innes N., et al. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Thorax: 1988; 43 1 57 60
63. Patterson J. E., Bradley J. M., Elborn J. S. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance. Chron Respir Dis: 2004; 1 3 127 130
64. Patterson J. E., Bradley J. M., Hewitt O., Bradbury I., Elborn J. S. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella. Respiration: 2005; 72 3 239 242
65. Dab I., Alexander F. The mechanism of autogenic drainage studied with flow volume curves. Monogr Paediatr: 1979; 10 50 53
66. App E. M., Kieselmann R., Reinhardt D., et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest: 1998; 114 1 171 177
67. Pfleger A., Theissl B., Oberwaldner B., Zach M. S. Self-administered chest physiotherapy in cystic fibrosis: a comparative study of high-pressure PEP and autogenic drainage. Lung: 1992; 170 6 323 330
68. Giles D. R., Wagener J. S., Accurso F. J., Butler-Simon N. Short-term effects of postural drainage with clapping vs autogenic drainage on oxygen saturation and sputum recovery in patients with cystic fibrosis. Chest: 1995; 108 4 952 954
69. Miller S., Hall D. O., Clayton C. B., Nelson R. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax: 1995; 50 2 165 169
70. Van Ginderdeuren F., Verbanck S., Van Cauwelaert K., et al. Chest physiotherapy in cystic fibrosis: short-term effects of autogenic drainage preceded by wet inhalation of saline versus autogenic drainage preceded by intrapulmonary percussive ventilation with saline. Respiration: 2008; 76 2 175 180
71. Geller D. The science of aerosol delivery in cystic fibrosis. Pediatr Pulmonol: 2008; 43 (S9): S5 S17
72. Silverman W. A., Altman D. G. Patients' preferences and randomised trials. Lancet: 1996; 347 8995 171 174
73. O'Connor C., Bridge P. Can the Interrupter Technique be used as an Outcome Measure for Autogenic Drainage in Bronchiectatic Patients? A Pilot Study. Journal of the Association of Chartered Physiotherapists in Respiratory Care: 2005; 37 29 34
74. Savci S., Ince D. I., Arikan H. A comparison of autogenic drainage and the active cycle of breathing techniques in patients with chronic obstructive pulmonary diseases. J Cardiopulm Rehabil: 2000; 20 1 37 43
75. Van Ginderdeuren F., Malfroot A., Verdonck J. Influence of assisted autogenic drainage (AAD) and AAD combined with bouncing on gastro-oesophageal reflux (GOR) in infants under the age of 5 months. J Cystic Fibrosis: 2003; 2 01 A251
76. Andersen J. B., Qvist J., Kann T. Recruiting collapsed lung through collateral channels with positive end-expiratory pressure. Scand J Respir Dis: 1979; 60 5 260 266
77. Groth S., Stafanger G., Dirksen H., Andersen J. B., Falk M., Kelstrup M. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir: 1985; 21 4 339 343
78. Falk M., Kelstrup M., Andersen J. B., et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis: 1984; 65 6 423 432
79. West K., Wallen M., Follett J. Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation. Physiother Theory Pract: 2010; 26 3 143 149
80. Braggion C., Cappelletti L. M., Cornacchia M., Zanolla L., Mastella G. Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study. Pediatr Pulmonol: 1995; 19 1 16 22
81. Lannefors L., Wollmer P. Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and physical exercise. Eur Respir J: 1992; 5 6 748 753
82. McIlwaine P. M., Wong L. T., Peacock D., Davidson A. G. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr: 1997; 131 4 570 574
83. McIlwaine P. M., Wong L. T., Peacock D., Davidson A. G. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr: 2001; 138 6 845 850
84. Valente A. M., Gastaldi A. C., Cravo S. L., Afonso J. L., Sologuren M. JJ, Guimaraes R. C. The effect of two techniques on the characteristics and transport of sputum in patients with bronchiectasis. A pilot study. Physiotherapy: 2004; 90 3 158 164
85. Costantini D., Brivio A., Brusa D., Delfino R., Fredella C., Russo M. PEP-mask versus postural drainage in CF infants a long-term comparative trial. Pediatric Pulmonology: 2001; 32 22 308
86. Heine R. G., Button B. M., Olinsky A., Phelan P. D., Catto-Smith A. G. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child: 1998; 78 1 44 48
87. Konstan M. W., Stern R. C., Doershuk C. F. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr: 1994; 124 5, Pt 1 689 693
88. van Winden C. M., Visser A., Hop W., Sterk P. J., Beckers S., de Jongste J. C. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. Eur Respir J: 1998; 12 1 143 147
89. Padman R., Geouque D. M., Engelhardt M. T. Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients. Del Med J: 1999; 71 1 13 18
90. Newbold M. E., Tullis E., Corey M., Ross B., Brooks D. The flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiother Can: 2005; 57 199 207
91. Volsko T. A., DiFiore J., Chatburn R. L. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care: 2003; 48 2 124 130
92. Guimarães F. S., Moço V. J., Menezes S. L., Dias C. M., Salles R. E., Lopes A. J. Effects of ELTGOL and Flutter VRP1® on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Rev Bras Fisioter: 2012; 16 2 108 113
93. Naraparaju S., Vaishali K., Venkatesan P., Acharya V. A comparison of the Acapella and a threshold inspiratory muscle trainer for sputum clearance in bronchiectasis-A pilot study. Physiother Theory Pract: 2010; 26 6 353 357
94. Figueiredo P. H., Zin W. A., Guimarães F. S. Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis. Physiother Res Int: 2012; 17 1 12 20
95. Murray M. P., Pentland J. L., Hill A. T. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J: 2009; 34 5 1086 1092
96. Lee A. L., Williamson H. C., Lorensini S., Spencer L. M. The effects of oscillating positive expiratory pressure therapy in adults with stable non-cystic fibrosis bronchiectasis: a systematic review. Chron Respir Dis: 2014
97. Mestriner R. G., Fernandes R. O., Steffen L. C., Donadio M. V. Optimum design parameters for a therapist-constructed positive-expiratory-pressure therapy bottle device. Respir Care: 2009; 54 4 504 508
98. Darbee J. C., Kanga J. F., Ohtake P. J. Physiologic evidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis. Phys Ther: 2005; 85 12 1278 1289
99. Oermann C. M., Sockrider M. M., Giles D., Sontag M. K., Accurso F. J., Castile R. G. Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study. Pediatr Pulmonol: 2001; 32 5 372 377
100. Warwick W. J., Hansen L. G. The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatr Pulmonol: 1991; 11 3 265 271
101. Osman L. P., Roughton M., Hodson M. E., Pryor J. A. Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. Thorax: 2010; 65 3 196 200
102. Gokdemir Y., Karadag-Saygi E., Erdem E., et al. Comparison of conventional pulmonary rehabilitation and high-frequency chest wall oscillation in primary ciliary dyskinesia. Pediatr Pulmonol: 2014; 49 6 611 616
103. Nicolini A., Cardini F., Landucci N., Lanata S., Ferrari-Bravo M., Barlascini C. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis. BMC Pulm Med: 2013; 13 21
104. Mahajan A. K., Diette G. B., Hatipoʇlu U., et al. High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial. Respir Res: 2011; 12 120
105. Fauroux B., Boulé M., Lofaso F., et al. Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics: 1999; 103 3 E32
106. Holland A. E., Denehy L., Ntoumenopoulos G., Naughton M. T., Wilson J. W. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax: 2003; 58 10 880 884
107. Moran F., Bradley J. M., Piper A. J. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev: 2009; 1 CD002769
108. Young A. C., Wilson J. W., Kotsimbos T. C., Naughton M. T. Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax: 2008; 63 1 72 77
109. Flight W. G., Shaw J., Johnson S., et al. Long-term non-invasive ventilation in cystic fibrosis - experience over two decades. J Cyst Fibros: 2012; 11 3 187 192
110. Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J: 1997; 10 9 1999 2003
111. Lima C. A., de Andrade AdeF, Campos S. L., et al. Effects of noninvasive ventilation on treadmill 6-min walk distance and regional chest wall volumes in cystic fibrosis: randomized controlled trial. Respir Med: 2014; 108 10 1460 1468
112. Paneroni M., Clini E., Simonelli C., Bianchi L., Degli Antoni F., Vitacca M. Safety and efficacy of short-term intrapulmonary percussive ventilation in patients with bronchiectasis. Respir Care: 2011; 56 7 984 988
113. Sivasothy P., Brown L., Smith I. E., Shneerson J. M. Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax: 2001; 56 6 438 444
114. Bradley J., Moran F. Physical training for cystic fibrosis. Cochrane Database Syst Rev: 2008; 1 CD002768
115. Dwyer T. J., Alison J. A., McKeough Z. J., Daviskas E., Bye P. T. Effects of exercise on respiratory flow and sputum properties in patients with cystic fibrosis. Chest: 2011; 139 4 870 877
116. Kim C. S., Rodriguez C. R., Eldridge M. A., Sackner M. A. Criteria for mucus transport in the airways by two-phase gas-liquid flow mechanism. J Appl Physiol (1985): 1986; 60 3 901 907
117. Hebestreit A., Kersting U., Basler B., Jeschke R., Hebestreit H. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis. Am J Respir Crit Care Med: 2001; 164 3 443 446
118. Daviskas E., Anderson S. D., Gonda I., Chan H. K., Cook P., Fulton R. Changes in mucociliary clearance during and after isocapnic hyperventilation in asthmatic and healthy subjects. Eur Respir J: 1995; 8 5 742 751
119. Kim C. S., Iglesias A. J., Sackner M. A. Mucus clearance by two-phase gas-liquid flow mechanism: asymmetric periodic flow model. J Appl Physiol (1985): 1987; 62 3 959 971
120. Ries A. L., Bauldoff G. S., Carlin B. W., et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest: 2007; 131 (5, Suppl): 4S 42S
121. ZuWallack R., Hedges H. Primary care of the patient with chronic obstructive pulmonary disease-part 3: pulmonary rehabilitation and comprehensive care for the patient with chronic obstructive pulmonary disease. Am J Med: 2008; 121 (7, Suppl): S25 S32
122. Newall C., Stockley R. A., Hill S. L. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax: 2005; 60 11 943 948
123. Bradley J., Moran F., Greenstone M. Physical training for bronchiectasis. Cochrane Database Syst Rev: 2002; 3 CD002166
124. Bilton D., Dodd M. E., Abbot J. V., Webb A. K. The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis. Respir Med: 1992; 86 6 507 511
125. Salh W., Bilton D., Dodd M., Webb A. K. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax: 1989; 44 12 1006 1008
126. Bilton D., Stanford G. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care? Curr Opin Pulm Med: 2014; 20 6 601 606
127. Balsamo R., Lanata L., Egan C. G. Mucoactive drugs. Eur Respir Rev: 2010; 19 116 127 133
128. Tomkiewicz R. P., App E. M., De Sanctis G. T., et al. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog. Pulm Pharmacol: 1995; 8 6 259 265
129. Bilton D., Tino G., Barker A. F., et al. B-305 Study Investigators. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax: 2014; 69 12 1073 1079
130. Williams R., Rankin N., Smith T., Galler D., Seakins P. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med: 1996; 24 11 1920 1929
131. Conway J. H., Fleming J. S., Perring S., Holgate S. T. Humidification as an adjunct to chest physiotherapy in aiding tracheo-bronchial clearance in patients with bronchiectasis. Respir Med: 1992; 86 2 109 114
132. Hasani A., Chapman T. H., McCool D., Smith R. E., Dilworth J. P., Agnew J. E. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis: 2008; 5 2 81 86
133. Mall M. A., Harkema J. R., Trojanek J. B., et al. Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am J Respir Crit Care Med: 2008; 177 7 730 742
134. Rea H., McAuley S., Jayaram L., et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med: 2010; 104 4 525 533
135. Shak S. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest: 1995; 107 (2, Suppl): 65S 70S
136. Jones A. P., Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev: 2010; 3 CD001127
137. Frederiksen B., Pressler T., Hansen A., Koch C., Hoiby N. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr: 2006; 95 9 1070 1074
138. Berge M. T., Wiel Ev, Tiddens H. A., Merkus P. J., Hop W. C., de Jongste J. C. DNase in stable cystic fibrosis infants: a pilot study. J Cyst Fibros: 2003; 2 4 183 188
139. Goss C. H., MacNeill S. J., Quinton H. B., et al. Children and young adults with CF in the USA have better lung function compared with the UK. Thorax: 2014;. doi: 10.1136/thoraxjnl-2014-205718 [Epub ahead of print]
140. O'Donnell A. E., Barker A. F., Ilowite J. S., Fick R. B. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest: 1998; 113 5 1329 1334
141. Wills P. J., Wodehouse T., Corkery K., Mallon K., Wilson R., Cole P. J. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am J Respir Crit Care Med: 1996; 154 2, Pt 1 413 417
142. Wilkinson M., Sugumar K., Milan S. J., Hart A., Crockett A., Crossingham I. Mucolytics for bronchiectasis. Cochrane Database Syst Rev: 2014; 5 CD001289
143. Elkins M. R., Robinson M., Rose B. R., et al. National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med: 2006; 354 3 229 240
144. Wills P. J., Hall R. L., Chan W., Cole P. J. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest: 1997; 99 1 9 13
145. Robinson M., Hemming A. L., Regnis J. A., et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax: 1997; 52 10 900 903
146. Eng P. A., Morton J., Douglass J. A., Riedler J., Wilson J., Robertson C. F. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol: 1996; 21 2 77 83
147. Amin R., Subbarao P., Jabar A., et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax: 2010; 65 5 379 383
148. Subbarao P., Balkovec S., Solomon M., Ratjen F. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatr Pulmonol: 2007; 42 5 471 476
149. Dellon E. P., Donaldson S. H., Johnson R., Davis S. D. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol: 2008; 43 11 1100 1106
150. Rosenfeld M., Ratjen F., Brumback L., et al. ISIS Study Group. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA: 2012; 307 21 2269 2277
151. Kellett F., Robert N. M. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir Med: 2011; 105 12 1831 1835
152. Nicolson C. H., Stirling R. G., Borg B. M., Button B. M., Wilson J. W., Holland A. E. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis. Respir Med: 2012; 106 5 661 667
153. Chang A. B., Bell S. C., Byrnes C. A., et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust: 2010; 193 6 356 365
154. Hart A., Sugumar K., Milan S. J., Fowler S. J., Crossingham I. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev: 2014; 5 CD002996
155. Amin R., Ratjen F. Emerging drugs for cystic fibrosis. Expert Opin Emerg Drugs: 2014; 19 1 143 155
156. Wills P., Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev: 2006; 2 CD002996
157. Bilton D., Bellon G., Charlton B., et al. CF301 and CF302 Investigators. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. J Cyst Fibros: 2013; 12 4 367 376
158. Daniels T. Physiotherapeutic management strategies for the treatment of cystic fibrosis in adults. J Multidiscip Healthc: 2010; 3 201 212
159. Daniels T., Mills N., Whitaker P. Nebuliser systems for drug delivery in cystic fibrosis. Cochrane Database Syst Rev: 2013; 4 CD007639
160. Dentice R., Elkins M. Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev: 2011; 5 CD007923
161. Elkins M., Dentice R. Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database Syst Rev: 2012; 2 CD008816
162. Daviskas E., Anderson S. D., Eberl S., Chan H. K., Young I. H. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest: 2001; 119 2 414 421
163. Burness C. B., Keating G. M. Mannitol dry powder for inhalation: in patients with cystic fibrosis. Drugs: 2012; 72 10 1411 1421
164. Daviskas E., Rubin B. K. Effect of inhaled dry powder mannitol on mucus and its clearance. Expert Rev Respir Med: 2013; 7 1 65 75
165. Elkins M. R., Anderson S. D., Perry C. P., Daviskas E., Charlton B. Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device. Open Respir Med J: 2014; 8 8 13
166. Elkins M. R., Robinson P., Anderson S. D., Perry C. P., Daviskas E., Charlton B. Inspiratory flows and volumes in subjects with cystic fibrosis using a new dry powder inhaler device. Open Respir Med J: 2014; 8 1 7
167. Collins N. Nebulizer therapy in cystic fibrosis: an overview. J R Soc Med: 2009; 102 01 11 17
168. Quittner A. L., Modi A. C., Lemanek K. L., Ievers-Landis C. E., Rapoff M. A. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol: 2008; 33 9 916 936, discussion 937-938
169. Glasscoe C. A., Quittner A. L. Psychological interventions for people with cystic fibrosis and their families. Cochrane Database Syst Rev: 2008; 3 CD003148
170. Daniels T. Nebuliser systems for drug delivery in cystic fibrosis. J Evid Based Med: 2013; 6 3 201
171. Daniels T., Goodacre L., Sutton C., Pollard K., Conway S., Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest: 2011; 140 2 425 432